Published in BMJ Open on May 17, 2017
Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA (1996) 14.23
Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet (2011) 9.37
The health care costs of smoking. N Engl J Med (1997) 8.59
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. Value Health (2003) 6.02
The Markov process in medical prognosis. Med Decis Making (1983) 3.58
Handling uncertainty in cost-effectiveness models. Pharmacoeconomics (2000) 3.37
Inconsistencies in the "societal perspective" on costs of the Panel on Cost-Effectiveness in Health and Medicine. Med Decis Making (1999) 2.82
A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess (2007) 2.62
Evidence for an association between environmental tobacco smoke exposure and birthweight: a meta-analysis and new data. Paediatr Perinat Epidemiol (1999) 2.11
Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect (1999) 2.11
Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer (2005) 2.10
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health (2005) 2.04
State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. Value Health (2012) 1.90
Measurement of environmental tobacco smoke exposure among adults with asthma. Environ Health Perspect (2001) 1.71
Environmental tobacco smoke and adult-onset asthma: a population-based incident case-control study. Am J Public Health (2003) 1.68
Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax (1997) 1.55
Meta-analysis of the association between secondhand smoke exposure and stroke. J Public Health (Oxf) (2011) 1.52
Household smoking bans and adolescent antismoking attitudes and smoking initiation: findings from a longitudinal study of a Massachusetts youth cohort. Am J Public Health (2008) 1.36
Effects of husbands' smoking on the incidence of lung cancer in Korean women. Int J Epidemiol (1999) 1.33
Cost of tobacco-related diseases, including passive smoking, in Hong Kong. Tob Control (2006) 1.32
Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol (2007) 1.27
Asthma incidence among children and adults: findings from the Behavioral Risk Factor Surveillance system asthma call-back survey--United States, 2006-2008. J Asthma (2012) 1.26
[Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database]. J Prev Med Public Health (2006) 1.22
Exposure of nonsmoking women to environmental tobacco smoke: a 10-country collaborative study. Cancer Causes Control (1990) 1.20
The total lifetime health cost savings of smoking cessation to society. Eur J Public Health (2005) 1.09
Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics. Pharmacoeconomics (2001) 1.03
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers. Pharmacoeconomics (2008) 1.03
The economic impact of exposure to secondhand smoke in Minnesota. Am J Public Health (2009) 0.95
Providing systematic guidance in pharmacoeconomic guidelines for analysing costs. Pharmacoeconomics (2005) 0.93
Environmental tobacco smoke exposure and risk of stroke in nonsmokers: a review with meta-analysis. J Stroke Cerebrovasc Dis (2007) 0.89
Development of the health and economic consequences of smoking interactive model. Tob Control (2001) 0.89
A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. Value Health (2010) 0.83
Medical costs of secondhand-smoke exposure in North Carolina. N C Med J (2011) 0.82
Pharmacologic-based strategies for smoking cessation: clinical and cost-effectiveness analyses. CADTH Technol Overv (2012) 0.80
Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromise. Pharmacoeconomics (2013) 0.79
[Costs of initial cancer care and its affecting factors]. J Prev Med Public Health (2009) 0.77
The effects of secondhand smoke on chronic obstructive pulmonary disease in nonsmoking Korean adults. Korean J Intern Med (2014) 0.77
The cost of secondhand smoke exposure at home in California. Tob Control (2014) 0.77
Staphylococcus aureus inhibits terminal differentiation of normal human keratinocytes by stimulating interleukin-6 secretion. J Dermatol Sci (2013) 0.81
Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins. J Dermatol Sci (2014) 0.80
Topical Application of Dieckol Ameliorates Atopic Dermatitis in NC/Nga Mice by Suppressing Thymic Stromal Lymphopoietin Production. J Invest Dermatol (2016) 0.75
Increased cis-to-trans urocanic acid ratio in the skin of chronic spontaneous urticaria patients. Sci Rep (2017) 0.75
Loss of Rab25 promotes the development of skin squamous cell carcinoma through the dysregulation of integrin trafficking. J Pathol (2019) 0.75